Fennec Pharmaceuticals Inc. - Common Stock — Bilan (NASDAQ:FENC) | MetaTrader

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Total de l'actif 31.42 M22.41 M26.94 M26.86 M44.95 M70.55 M Total du passif 2.35 M6.64 M29.51 M38.49 M50.82 M35.08 M Total des capitaux propres 29.07 M15.77 M-2.57 M-11.62 M-5.87 M35.47 M Total du passif et des capitaux propres 31.42 M22.41 M26.94 M26.86 M44.95 M70.55 M Dette totale —————— Dette nette ——————

Nouvelles

Do Options Traders Know Something About Adherex Technologies Stock We Don't?

Adherex Technologies Inc. (FENC) Beats Q1 Earnings and Revenue Estimates

L’action Fennec Pharmaceuticals grimpe de 3% après des résultats supérieurs aux attentes

MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates

Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Lags Revenue Estimates

Fennec Pharmaceuticals : résultats T4 2025 décevants

Adherex Technologies Inc. (FENC) Reports Q4 Loss, Misses Revenue Estimates

Fennec Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Fennec Pharmaceuticals (NASDAQ:FENC)

Gossamer Bio (GOSS) Reports Q4 Loss, Beats Revenue Estimates

Gyre Therapeutics, Inc. (GYRE) Q4 Earnings Miss Estimates

Earnings Preview: Gossamer Bio (GOSS) Q4 Earnings Expected to Decline

Adherex Technologies Inc. (FENC) Earnings Expected to Grow: What to Know Ahead of Q4 Release